These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11195456)

  • 1. Transgenic mouse models for lung cancer.
    Zhao B; Magdaleno S; Chua S; Wang YL; Burcin M; Elberg D; Finegold M; Tsai S; DeMayo FJ
    Exp Lung Res; 2000 Dec; 26(8):567-79. PubMed ID: 11195456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical analysis of Clara cell secretory protein expression in a transgenic model of mouse lung carcinogenesis.
    Hicks SM; Vassallo JD; Dieter MZ; Lewis CL; Whiteley LO; Fix AS; Lehman-McKeeman LD
    Toxicology; 2003 May; 187(2-3):217-28. PubMed ID: 12699910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decoding c-Myc networks of cell cycle and apoptosis regulated genes in a transgenic mouse model of papillary lung adenocarcinomas.
    Ciribilli Y; Singh P; Spanel R; Inga A; Borlak J
    Oncotarget; 2015 Oct; 6(31):31569-92. PubMed ID: 26427040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemopreventive effects of gefitinib on nonsmoking-related lung tumorigenesis in activating epidermal growth factor receptor transgenic mice.
    Ohashi K; Takigawa N; Osawa M; Ichihara E; Takeda H; Kubo T; Hirano S; Yoshino T; Takata M; Tanimoto M; Kiura K
    Cancer Res; 2009 Sep; 69(17):7088-95. PubMed ID: 19690148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin-dependent kinase inhibitor expression in pulmonary Clara cells transformed with SV40 large T antigen in transgenic mice.
    Magdaleno SM; Wang G; Mireles VL; Ray MK; Finegold MJ; DeMayo FJ
    Cell Growth Differ; 1997 Feb; 8(2):145-55. PubMed ID: 9040936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Shp2 suppresses mutant EGFR-induced lung tumors in transgenic mouse model of lung adenocarcinoma.
    Schneeberger VE; Ren Y; Luetteke N; Huang Q; Chen L; Lawrence HR; Lawrence NJ; Haura EB; Koomen JM; Coppola D; Wu J
    Oncotarget; 2015 Mar; 6(8):6191-202. PubMed ID: 25730908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simian virus 40 large T antigen directed by transcriptional elements of the human surfactant protein C gene produces pulmonary adenocarcinomas in transgenic mice.
    Wikenheiser KA; Clark JC; Linnoila RI; Stahlman MT; Whitsett JA
    Cancer Res; 1992 Oct; 52(19):5342-52. PubMed ID: 1394139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of transgenic mice that inducibly express an active form of c-Src in the epidermis.
    Matsumoto T; Kiguchi K; Jiang J; Carbajal S; Ruffino L; Beltrán L; Wang XJ; Roop DR; DiGiovanni J
    Mol Carcinog; 2004 Aug; 40(4):189-200. PubMed ID: 15264211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung-specific expression of dominant-negative mutant p53 in transgenic mice increases spontaneous and benzo(a)pyrene-induced lung cancer.
    Tchou-Wong KM; Jiang Y; Yee H; LaRosa J; Lee TC; Pellicer A; Jagirdar J; Gordon T; Goldberg JD; Rom WN
    Am J Respir Cell Mol Biol; 2002 Aug; 27(2):186-93. PubMed ID: 12151310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive activation of Notch3 inhibits terminal epithelial differentiation in lungs of transgenic mice.
    Dang TP; Eichenberger S; Gonzalez A; Olson S; Carbone DP
    Oncogene; 2003 Apr; 22(13):1988-97. PubMed ID: 12673204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of transgenic carcinoembryonic antigen (CEA) in tumor-prone mice: an animal model for CEA-directed tumor immunotherapy.
    Thompson JA; Eades-Perner AM; Ditter M; Muller WJ; Zimmermann W
    Int J Cancer; 1997 Jul; 72(1):197-202. PubMed ID: 9212243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arrested lung morphogenesis in transgenic mice bearing an SP-C-TGF-beta 1 chimeric gene.
    Zhou L; Dey CR; Wert SE; Whitsett JA
    Dev Biol; 1996 May; 175(2):227-38. PubMed ID: 8626028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a Conditional Transgenic Mouse Model Recapitulating EML4-ALK-Positive Human Non-Small Cell Lung Cancer.
    Pyo KH; Lim SM; Kim HR; Sung YH; Yun MR; Kim SM; Kim H; Kang HN; Lee JM; Kim SG; Park CW; Chang H; Shim HS; Lee HW; Cho BC
    J Thorac Oncol; 2017 Mar; 12(3):491-500. PubMed ID: 27836576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical use of advanced mouse models for lung cancer.
    Safari R; Meuwissen R
    Methods Mol Biol; 2015; 1267():93-124. PubMed ID: 25636466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting KRAS mutation-bearing lung cancer in vivo by pulmonary surfactant-adenovirus-mediated gene transfer.
    Fukazawa T; Maeda Y; Matsuoka J; Ono T; Mominoki K; Yamatsuji T; Shigemitsu K; Morita I; Murakami I; Tanaka H; Durbin ML; Naomoto Y
    Anticancer Res; 2010 Dec; 30(12):4925-35. PubMed ID: 21187472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic mice bearing the polyomavirus large T antigen directed by 2.1 kb of the keratin 19 promoter develop bronchiolar papillary tumors with progression to lung adenocarcinomas.
    Lebel M; Webster M; Muller WJ; Royal A; Gauthier J; Mes-Masson AM
    Cell Growth Differ; 1995 Dec; 6(12):1591-600. PubMed ID: 9019164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A model of pulmonary adenocarcinoma in transgenic mice expressing the simian virus 40 T antigen driven by the rat Calbindin-D9K (CaBP9K) promoter.
    Chailley-Heu B; Rambaud C; Barlier-Mur AM; Galateau-Salle F; Perret C; Capron F; Lacaze-Masmonteil T
    J Pathol; 2001 Nov; 195(4):482-9. PubMed ID: 11745681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of a fusion gene consisting of the mouse growth hormone-releasing hormone gene promoter linked to the SV40 T-antigen gene in transgenic mice.
    Nogues N; Magnan E; De Grandis P; Butz M; Kineman RD; Kopchick JJ; Frohman LA
    Mol Cell Endocrinol; 1998 Feb; 137(2):161-8. PubMed ID: 9605518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The uteroglobin promoter targets expression of the SV40 T antigen to a variety of secretory epithelial cells in transgenic mice.
    Sandmöller A; Halter R; Gómez-La-Hoz E; Gröne HJ; Suske G; Paul D; Beato M
    Oncogene; 1994 Oct; 9(10):2805-15. PubMed ID: 8084586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and characterization of JSRV envelope transgenic mice in FVB background.
    Chitra E; Yu SL; Hsiao KN; Shao HY; Sia C; Chen IH; Hsieh SY; Chen JH; Chow YH
    Virology; 2009 Oct; 393(1):120-6. PubMed ID: 19695657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.